Design, Synthesis, and Biological Evaluations of a Novel Resveratrol-Type Analogue Against VEGF
Vascular endothelial growth factor (VEGF), also known as VEGF-A, has been reported to mediate various diseases, including cancer and wet age-related macular degeneration (wAMD). Despite the fact that VEGF inhibitors are commercially available and appear to be effective in clinical applications, adve...
Saved in:
| Main Authors: | Shengying Lin, Maggie Suisui Guo, Roy Wai-Lun Tang, Yutong Ye, Jiahui Wu, Yuen Man Ho, Ran Duan, Ka Wing Leung, Tina Ting-Xia Dong, Karl Wah-Keung Tsim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/11/2345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of VEGF Signal Pathway on Etiopathogenesis and AntiVEGF Treatments in Childhood Cancers
by: Ali Kazdal, et al.
Published: (2023-09-01) -
Effects of aerobic training and combination of resveratrol and fisetin on brain neurogenesis signaling pathways in Alzheimer’s mice
by: Amir Jahanbakhsh, et al.
Published: (2024-12-01) -
Angiogenesis Induced by HIF1α and VEGF as Pathophysiological Cause of Glaucoma
by: Burim Neziri, et al.
Published: (2025-06-01) -
Influence of VEGF deprivation upon vascular formation by endothelium in the presence of macrophages
by: A. R. Kozyreva, et al.
Published: (2020-04-01) -
Resveratrol as a Novel Therapeutic Approach for Diabetic Retinopathy: Molecular Mechanisms, Clinical Potential, and Future Challenges
by: Snježana Kaštelan, et al.
Published: (2025-08-01)